Abstract
Objective To evaluate the potential clinical value of quantitative functional FDG PET and pathological amyloid-β PET with cerebrospinal fluid (CSF) biomarkers and clinical assessments in the prediction of Alzheimer's disease (AD) progression.
Cite
CITATION STYLE
APA
Chen, X., Zhou, Y., Wang, R., Cao, H., Reid, S., Gao, R., & Han, D. (2016). Potential clinical value of multiparametric pet in the prediction of Alzheimer’s disease progression. PLoS ONE, 11(5). https://doi.org/10.1371/journal.pone.0154406
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free